PXYN Stock Overview
A health care company, provides medical practitioners with medications and services for their patients. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Praxsyn Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 0% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| PXYN | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | n/a | 14.2% | 32.3% |
Return vs Industry: Insufficient data to determine how PXYN performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how PXYN performed against the US Market.
Price Volatility
| PXYN volatility | |
|---|---|
| PXYN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PXYN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PXYN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Sean Daly | www.praxsyn.com |
Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers’ compensation system, as well as preferred provider contracts.
Praxsyn Corporation Fundamentals Summary
| PXYN fundamental statistics | |
|---|---|
| Market cap | US$847.00 |
| Earnings (TTM) | US$6.91m |
| Revenue (TTM) | US$63.50m |
0.0x
P/E Ratio0.0x
P/S RatioIs PXYN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PXYN income statement (TTM) | |
|---|---|
| Revenue | US$63.50m |
| Cost of Revenue | US$7.23m |
| Gross Profit | US$56.27m |
| Other Expenses | US$49.36m |
| Earnings | US$6.91m |
Last Reported Earnings
Sep 30, 2015
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PXYN perform over the long term?
See historical performance and comparison